UNCONTROLLED WHEN PRINTED

Definition:

  • Acute coronary syndrome (ACS) represents in a range of clinical presentations sharing common pathology, causing a reduced blood flow to the heart, ranging from worsening/unstable angina, prolonged chest pain, irregular pulse and ECG changes such as ST-elevation MI (STEMI).
  • Most patients present with prolonged (>10mins) or recurrent central chest discomfort described as tightness, heaviness, squeezing or crushing sensation.  The absence of these symptoms does not rule out ACS.

Key Terms

  • Angina (pectoris): Chest pain caused by myocardiac ischemia
    • Stable angina: Angina pain develops when there is increased demand in the setting of a stable atherosclerotic plaque. The vessel is unable to dilate enough to allow adequate blood flow to meet the myocardial demand.
    • Unstable angina: The plaque ruptures and a thrombus forms around the ruptured plaque, causing partial occlusion of the vessel. Angina pain occurs at rest or progresses rapidly over a short period of time.
  • Atherosclerosis:
    • The most common form of arteriosclerosis, characterised by soft deposits of intra-arterial fat and fibrin in the vessels walls that harden over time. Fatty lesions develop between the tunica intima and media of the vessel walls, narrowing the lumen of the vessel. These lesions can grow large enough to occlude blood flow, or they can rupture and cause the sudden development of a clot that occludes the blood vessel.
  • Arteriosclerosis:
    • The thickening, hardening, and loss of elasticity of the walls of arteries. This process gradually restricts the blood flow to one's organs and tissues and can lead to severe health risks brought on by atherosclerosis.
  • Atheroma
    • An atheroma, or atheromatous plaque ("plaque"), is an abnormal accumulation of material in the inner layer of the wall of an artery; it is present in the arteries of most adults. The material consists of mostly macrophage cells, or debris, containing lipids, calcium and a variable amount of fibrous connective tissue.
  • Myocardial Infarction
    • A heart attack or acute myocardial infarction (AMI) occurs when one of the arteries that supplies the heart muscle becomes blocked. Blockage may be caused by spasm of the artery or by atherosclerosis with acute clot formation. The blockage results in damaged tissue and a permanent loss of contractility of this portion of the heart muscle (this is called tissue necrosis). The infarcted area continues to grow until circulation to that area is restored. Infarcted myocardium becomes non-functional and is gradually replaced by fibrous tissue. The presence of collateral circulation can reduce the amount of infarction; these pathways can develop over time with short episodes of ischaemia creating new pathways to perfuse tissue.

Pathophysiology

Atherosclerosis

Injury to the endothelial cells that line the inner layer of the coronary artery occurs.The injured endothelium becomes dysfunctional, initiating an inflammatory response.

Low-density lipoproteins (LDL) infiltrate the damaged endothelium and accumulate in the intima of the coronary artery.The LDLs become oxidised as a result of exposure to free radicals including nitric oxide. Oxidation of the LDLs causes monocytes and T-lymphocytes to migrate into the intima.

Monocytes differentiate into macrophages, and engulf the large amounts of LDLs by phagocytosis. After macrophages become laden with lipid from ingesting LDLs, they are referred to as foam cells. Eventually, foam cells undergo apoptosis and die, but the contained lipids accumulate in the tunica intima forming a lesion called a fatty streak.

T-lymphocytes are activated and secrete cytokines, mediators and growth factors that promote smooth muscle cell migration from the media to the intima.

The smooth muscle cells proliferate, and deposit elastin and collagen on the surface of the fatty streak. This causes the formation of a fibrous capsule that covers the original fatty streak. As a result, a fibrous plaque (atheroma) is formed.

Initially, the vessel wall will expand to accommodate the growing fibrous plaque,but eventually the plaque will protrude into the lumen of the artery. The extrusion of fibrous plaque disrupts the smooth arterial lining and results in an uneven surface; this creates turbulent blood flow.

Two types of fibrous plaques can be defined, stable and unstable.

  • Stable plaques have a thick, intact fibrous capsule. These plaques are not prone to rupture, and the atheroma gradually expands to occlude the vessel.
  • Unstable plaques have a thin fibrous capsule. These plaques are prone to rupture.

When rupture occurs, platelets aggravate at the injured tissue and initiate the coagulation cascade. This results in the formation of a thrombus.

The acute thrombus may suddenly occlude the affected vessel, causing an acute coronary syndrome. This can result in ischaemia and/or infarction.

Angina Pectoris:

  • Stable angina:
    • Blood flow adequate at rest
    • Upon exertion, there is an iIncreased oxygen demand
    • Arteriosclerosis/atherosclerosis limits blood flow
    • Pain usually lasts 5 – 15 minutes
    • Relieved by rest
    • Nil ECG changes
    • No permanent damage to myocardium
  • Unstable angina:
    • Blood flow interrupted by rupture of unstable plaque and resultant clot
    • Pain at rest
    • May also present with nausea, SOB and diaphoresis
    • May have ECG changes
    • T – wave inversion
    • ST depression
    • No permanent damage to myocardium
  • Myocardial infarction:
    • Biomarkers released (troponin, creatine kinase)
    • NSTEMI
      • May be complete or near-complete vessel occlusion
      • If complete occlusion usually a smaller vessel
      • Tissue Death to partial thickness of the myocardium
      • ECG changes include T wave inversion and ST depression. Typically ST Elevation is not present or not meeting criteria.
    • STEMI
      • Complete occlusion of larger artery
      • Results in death of full thickness of myocardium
      • ECG changes include ST Elevation in 2 or more contiguous leads (minimum voltage limits). ST depression may be present in other leads.

ACSPathway

Risk Factors

Modifiable:

  • Diet
  • Sedentary lifestyle
  • Cigarette smoking
  • Alcohol
  • Dyslipidaemia
  • Hypercholesterolaemia
  • Hypertension
  • Diabetes mellitus
  • Obesity

Non-modifiable:

  • Advance age (50+)
  • Male gender or females after menopause.
  • Family history.
  • Ethnicity

Cardiac Anatomy

  • Right Coronary Artery; supplies blood to:
    • Right atrium
    • Right ventricle
    • Sinoatrial (SA) node (55%)
    • Atrioventricular (AV) node (90%)
    • Inferior Left Ventricle
    • Posterior Left Ventricle
  • Left Coronary Artery; supplies blood to:
    • Left atrium (circumflex)
    • Sinoatrial (SA) node (45%, via circumflex)
    • Atrioventricular (AV) node (10%, via circumflex)
    • Lateral left ventricle
    • Anterior left ventricle (via Left Anterior Descending artery)
    • Intraventricular septum (via Left Anterior Descending artery)
    • Bundle Branches (via Left Anterior Descending artery)
  • Left Anterior Descending Artery: The LAD artery is the most commonly occluded of the coronary arteries. It provides the major blood supply to the interventricular septum, and thus bundle branches of the conducting system (complications seen include a right bundle branch block (or RBBB) and left bundle branch block (or LBBB)).
    • In general, the LAD artery and its branches supply most of the interventricular septum; the anterior, lateral, and apical wall of the left ventricle, most of the right and left bundle branches, and the anterior papillary muscle of the bicuspid valve (left ventricle).

Signs and Symptoms:

  • Chest pain/discomfort (ache, pressure, tightness, heaviness, burning)
  • Pain radiating to jaw, arms, back, shoulders, neck, upper abdomen
  • Nausea and/or vomiting
  • Indigestion-like feeling
  • SOB (dyspnoea)
  • Diaphoresis
  • Lightheaded, dizzy, syncope
  • Fatigue
  • Feeling of restlessness or apprehension

Treatment:

  • The principles of management of ACS are based on reducing the imbalance between oxygen demand and supply.
  • Coronary blood flow is improved by reversing vasoconstriction, preventing clotting, and reducing plaque growth and rupture.
  • Myocardial oxygen consumption is reduced by manipulation of blood pressure, heart rate, contractility, and left ventricular volume.

Documentation:

Information Needed:

Pain:        

  • Nature - what does the pain feel like? (Mild, crushing, vice like).
  • Severity - use PAINLOGTM to assess.
  • Onset - when did it start? At rest and/or on physical exertion?
  • Duration - intermittent, constant?
  • Location - may be left side or retrosternal (behind the sternum/breastbone).
  • Radiation - one/both arms, jaw, back?
  • Aggravating or alleviating factors - effects of position, movement?
  • Change on inhalation / exhalation - Does taking a deep breath make the pain worse or does it stay the same?

Notes:

  • A Normal ECG does not rule out Acute Coronary Syndrome (ACS).
  • Monitor Vital Signs and cardiac rhythm (if possible) via ‘dot’ electrodes en route.  Watch for sudden cardiac arrest.  Reassure continually. Only apply Multi Function Pads to a patient that is unconscious and pulseless. 
  • If a patient goes into cardiac arrest while you are monitoring them on the dot electrodes, it will be necessary to remove them before applying the multi function pads.
  • Suspicion of acute myocardial ischaemia ( ) is based entirely on field history. Do not be reassured by a "normal" rhythm strip.  Treat the patient not the rhythm!
  • Constant monitoring of the patient is essential. As many as 50% of patients who develop ventricular fibrillation in this setting may have NO warning arrhythmia!
  • All suspected patients are a life-threatening emergency, until a defibrillator is attached to the patient to revert sudden VF.

Critical points for Patient Care Record Form:

  • Observe and record any complications, which may be present:
    • Arrhythmias.
    • Pulmonary Oedema.
    • Cardiogenic shock.
    • Dyspnoea.
    • Nausea and vomiting.
    • Degree of pain (occasionally patients do not have pain though they have the other signs / symptoms of a heart attack).
    • Note: If an IV is in place, state the flow rate and who inserted the IV (doctor or paramedic’s name).

References
References

Page contributors:

DefaultDefault Author
St John WA
Want to help improve this article? Visit our Contribute page.

Clinical Resources Website

St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.

Other users – Terms of Use

The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.

St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.

St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website. 

No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au

Where links are provided to resources on external websites, St John WA:

  • Gives no assurances about the quality, accuracy or relevance of material on any linked site;
  • Accepts no legal responsibility regarding the accuracy and reliability of external material; and
  • Does not endorse any material, associated organisation, product or service on other sites.

Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.

To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).

Cookies

Please read this cookie policy carefully before using Clinical Resources from St John WA.

The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.

Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.

If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.

St John Ambulance Western Australia Ltd © Copyright 2020, All Rights Reserved

Terms of Use | Privacy Policy | Copyright Statement & Disclaimer